|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-2-27
|
|
pubmed:abstractText |
Thyroid hormone administration is associated with low bone density in some studies. The aim of the present study was to evaluate the influence L-thyroxine, in doses used to treat patients with a history of thyroid carcinoma, on serum cathepsin K and other markers of bone metabolism. Cathepsin K is thought to have a role in osteoclast mediated bone resorption.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1050-7256
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
27-33
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:18302515-Adult,
pubmed-meshheading:18302515-Aged,
pubmed-meshheading:18302515-Aged, 80 and over,
pubmed-meshheading:18302515-Biological Markers,
pubmed-meshheading:18302515-Bone Resorption,
pubmed-meshheading:18302515-Bone and Bones,
pubmed-meshheading:18302515-Carcinoma, Papillary,
pubmed-meshheading:18302515-Case-Control Studies,
pubmed-meshheading:18302515-Cathepsin K,
pubmed-meshheading:18302515-Cathepsins,
pubmed-meshheading:18302515-Collagen,
pubmed-meshheading:18302515-Dose-Response Relationship, Drug,
pubmed-meshheading:18302515-Humans,
pubmed-meshheading:18302515-Male,
pubmed-meshheading:18302515-Middle Aged,
pubmed-meshheading:18302515-Osteoprotegerin,
pubmed-meshheading:18302515-Peptide Fragments,
pubmed-meshheading:18302515-Thyroid Neoplasms,
pubmed-meshheading:18302515-Thyroxine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy.
|
|
pubmed:affiliation |
Department of Internal Medicine II, Klagenfurt State Hospital, Klagenfurt, Austria. peter.mikosch@tele2.at
|
|
pubmed:publicationType |
Journal Article
|
